LifeScience Vaccines

WestGene Achieves FDA Approval for World's First EB Virus-Related mRNA Cancer Vaccine, WGc-043

WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, ...

 May 13, 2024 | News

Pfizer's Innovative Single-Dose Bivalent RSV Vaccine Approved in Hong Kong and Macau

  The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B disease through two seasons has been approved by Hong K...

 May 09, 2024 | News

GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships

The Global Health Innovative Technology (GHIT) Fund  announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...

 May 09, 2024 | News

Infinitopes Raises £12.8M to Expand Precision Immunomics™ for Five Additional Cancers

      - Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen disco...

 May 01, 2024 | News

GSK Leads Adult Immunization Efforts in Malaysia for a Healthier Aging Population

As Malaysia's population shifts towards an ageing demographic, the importance of adult immunisation becomes increasingly apparent. By ensuring that individ...

 April 26, 2024 | News

YS Biopharma's New HBV Vaccine Gains Clinical Trial Approval in the Philippines

YS Biopharma, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therap...

 April 19, 2024 | News

AHF Denounces Moderna’s Backtracking on African mRNA Factory as a Blow to Global Health Equity

In a scathing rebuke, the AIDS Healthcare Foundation (AHF) has criticized Moderna for suspending its plans to build a state-of-the-art mRNA manufacturing f...

 April 15, 2024 | News

YS Biopharma Reports Positive Phase 3 Results for Its PIKA Rabies Vaccine

YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturi...

 April 10, 2024 | News

Clover Biopharmaceuticals Announces Promising Phase I Results for Its RSV Vaccine Candidate

 Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovat...

 April 09, 2024 | News

Recbio and Rongsheng Biotech Sign Partnership for New Adjuvant Vaccine Project

Jiangsu Recbio Technology Co., Ltd. (hereafter referred to as Recbio; stock code: 02179.HK) and Shanghai Rongsheng Biotech Co.,Ltd.(hereafter referred...

 March 27, 2024 | Company results

Altamira Therapeutics Partners with Univercells to Enhance mRNA Vaccine Delivery

 Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company providing nanoparticle-based technology for...

 March 26, 2024 | News

India Launches Pioneering Trials for MTBVAC TB Vaccine by Biofabri and Bharat Biotech to Revolutionize Global TB Prevention

Innovative Tuberculosis Vaccine, MTBVAC, Enters Clinical Trials in India In a major leap forward in the fight against tuberculosis (TB)—a deadly inf...

 March 24, 2024 | News

SK bioscience Breaks Ground in Southeast Asia and Southern Hemisphere with 440,000 Dose Vaccine Export to Thailand

Company exported 440,000 doses to Thailand, marking its entry into the Southeast Asian market and the Southern Hemisphere market. Company has obtained m...

 March 21, 2024 | News

New Phase 3 Trial Begins for Potential Tuberculosis Vaccine M72/AS01E

The Bill & Melinda Gates Medical Research Institute (Gates MRI) has initiated a large-scale Phase 3 trial to evaluate the effic...

 March 20, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close